Meddenovo Drug Design Revenue

Biotechnology Research • Villeurbanne, Auvergne-Rhône-Alpes, France • 1-10 Employees

Meddenovo Drug Design revenue & valuation

Annual revenue	$598,885
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,000,000
Total funding	$1,100,000

Key Contacts at Meddenovo Drug Design

Ilke Ugur Marion

Co-Founder & Ceo

Antoine Marion

Co-Founder And Cto

Company overview

Headquarters	Villeurbanne, Auvergne-Rhône-Alpes, France
Website	meddenovo.com
NAICS	541714
Founded	2023
Employees	1-10
Socials

Meddenovo Drug Design Email Formats

Meddenovo Drug Design uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@meddenovo.com), used 40% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@meddenovo.com	40%
{first initial}.{last name}	j.doe@meddenovo.com	40%
{first name}.{last name}	john.doe@meddenovo.com	20%

About Meddenovo Drug Design

Meddenovo is advancing AI-driven drug discovery with a specialized technology platform designed specifically for cyclic peptides. Our platform can design cyclic peptides from scratch, even without prior experimental data, and incorporates cutting-edge technology to capture their chameleon-like properties, including cell permeability. This unique capability enables us to address previously undruggable targets with precision. Cyclic peptides are a transformative class of compounds in pharmaceutical research, offering the advantages of both small molecules and large biologics, such as exceptional binding affinities, stability, and specificity. Technological advancements in the past decade have made peptides more accessible, and AI-driven companies like Meddenovo are now working to unlock their full potential to find cures for more diseases. At Meddenovo, we are committed to precision and reliability in drug discovery. Our approach reduces failure rates and accelerates the journey from research to market, empowering scientists worldwide with advanced, user-friendly AI tools. By democratizing access to sophisticated drug discovery technologies, we enable a broader community to contribute to innovative treatments. Discover how Meddenovo can transform your drug discovery process. With our advanced technologies and dedication to excellence, we are your partner in creating the next generation of medicines. Contact us today to learn more about custom access to our platform.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

C-Suite

Manager

Employees by Department

Meddenovo Drug Design has 7 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore Meddenovo Drug Design's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-08-31	2	$1,100,000
2025-02-01	3	N/A

Funding Insights

$1,100,000

Total funding amount

Number of funding rounds

Meddenovo Drug Design Tech Stack

Discover the technologies and tools that power Meddenovo Drug Design's digital infrastructure, from frameworks to analytics platforms.

Google Workspace

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

GoDaddy

Hosting

PHP

Programming languages

OWL Carousel

JavaScript libraries

Bootstrap

UI frameworks

Animate.css

UI frameworks

Popper

Miscellaneous

Frequently asked questions

Meddenovo Drug Design is located in Villeurbanne, Auvergne-Rhône-Alpes, FR.

Meddenovo Drug Design generates an estimated annual revenue of $598,885. This revenue figure reflects the company's market position and business performance in its industry.

Meddenovo Drug Design has an estimated valuation of $2,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Meddenovo Drug Design was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

Meddenovo Drug Design has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Meddenovo Drug Design has raised a total of $1,100,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Meddenovo Drug Design

Ilke Ugur Marion

Co-Founder & Ceo

Antoine Marion

Co-Founder And Cto

4.8

40,000 users